Certain chemicals in the blood were linked to how MS affects daily abilities, but a blood test based on them is not ready for use in care.
Researchers studied 323 people with MS and measured 332 chemicals in their blood. They compared those chemicals with walking, hand use, thinking speed, scans, and people’s own reports of how they felt. Some chemicals were linked to more severe MS across several of these measures. Other chemicals were linked to better results, like clues on a dashboard pointing toward a smoother ride. The study also found groups of related chemicals that may help researchers understand what is happening in MS.
This research matters to people with MS because changes in walking or thinking can be hard to capture with one checkup. A blood sample might one day give care teams another way to watch for changes, alongside exams and scans. Caregivers may find it useful to know why researchers are looking for easier ways to track how MS affects daily life. For now, keep telling your care team about changes you notice, even if a scan or test seems unchanged. Researchers and healthcare providers can use these findings to study whether blood chemicals reliably reflect MS symptoms over time.
The study looked for links at points in time, so it cannot show that these chemicals cause MS symptoms or predict future changes. The findings need to be checked in other groups of people with MS before they can guide care. They do not show that changing your diet, taking supplements, or changing treatment would improve these blood measures or MS symptoms.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More11/1/2026
Learn how brain support cells may affect inflammation in MS, why their roles can change, and what th
Read More11/1/2026
A positive MOG antibody test does not rule out MS. Learn why follow-up scans and symptom reviews may
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Neurology(R) neuroimmunology & neuroinflammation often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.